AVAVA is a Boston-based medical aesthetics company developing energy-based skin treatment devices built around its patented Focal Point Technology, which delivers energy with precision while preserving surrounding tissue. The technology is designed to enable highly customizable treatments across a broad range of skin types and body areas, supported by integrated cooling and a connected digital ecosystem for patients and providers. Co-founded by dermatology researcher Dr. R. Rox Anderson and led by CEO Clint Carnell, the company serves a global provider network and is expanding internationally.
1
Round
1
Industry
4
Tags
Sep 17, 2026
Latest raise
Funding activity · 1 round
Sep 17, 2026
$30M
Series B
Led by Catalio Capital Management
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
